Inhibrx Biosciences, Inc.· @inhibrx · X·· 16 小时前评分60
正文 · 原文
Inhibrx is heading to #ESMO2026, where data from the primary analysis of the phase 2 HexAgon-HN study evaluating ordastobart (INBRX-106) will be presented. 📅 Oct. 25 | 8:30–8:30–8:40 AM CET 📍 Booth #1077, Hall 10 Session details: https://t.co/cGgQNmYPRc https://t.co/09gpprjbaB
热度 0 · 0 赞 · 0 回复 · 0 转发
来源：Inhibrx Biosciences, Inc. · x.com